Company Profiles

driven by the PitchBook Platform

Qu Biologics

Qu Biologics
2007 FOUNDED
PRIVATE STATUS
51-200 EMPLOYEES
Angel LATEST DEAL TYPE
$3.11M LATEST DEAL AMOUNT
$20.2M TOTAL AMOUNT RAISED
Description

Developer of a site specific immunotherapy. The company develops site specific immunomodulators that stimulate activated innate immune cell recruitment to the targeted organ or tissue to restore immune function and treat a range of chronic diseases, including cancer and inflammatory bowel disease.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Primary Office
887 Great Northern Way
Suite 138
Vancouver, British Columbia V5T 4T5
Canada

+1 (604) 734-1450
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Qu Biologics’s full profile, request a free trial.

Qu Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Angel (individual) 12-Apr-2016 $3.11M $20.2M Completed Clinical Trials - Phase 2
6. Grant 06-Apr-2016 00000 000.00 Completed Clinical Trials - Phase 2
5. Angel (individual) 23-Dec-2015 00.000 000.00 Completed Generating Revenue
4. Angel (individual) 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 17-Sep-2014 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 01-Jun-2012 $5M $5M Completed Startup
1. Grant 25-May-2012 $3.1M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Qu Biologics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Genome British Columbia Not-For-Profit Venture Capital 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
National Research Council Canada Government 000 0000 000000 0
The Scientific Research and Experimental Development Government 000 0000 000000 0

Qu Biologics Executive Team (8)

Name Title Board
Seat
Contact
Info
Hal Gunn MD Chief Executive Officer, Board Member & Co-Founder
David Mullins Ph.D Chief Scientific Officer
Rob Freeman Co-Founder
Bob Cory Vice President, Business Development
Jim Pankovich Vice President, Clinical Operations & Drug Development
You’re viewing 5 of 8 executives. Get the full list »

Qu Biologics Board Members (4)

Name Representing Role Since Contact
Info
Hal Gunn MD Qu Biologics Chief Executive Officer, Board Member & Co-Founder 000 0000
Julia Levy Ph.D Self Board Member 000 0000
Robert Pelzer Self Board Member 000 0000
Simon Sutcliffe MD Self Chief Medical Officer & Board Member 000 0000